1) genciclovir
更昔络韦
1.
ObjectiveTo investigate the therapeutic effect of genciclovir on cytomegalovirus (CMV) infection of children with cerebral palsy (CP).
目的观察更昔络韦治疗脑瘫患儿巨细胞病毒(CMV)感染的疗效。
2) ganciclovir
更昔洛韦
1.
Compatible stabilities of glucose and sodium chloride potassium chloride injection mixing with aciclovir and ganciclovir for injection;
葡萄糖氯化钠钾注射液与注射用阿昔洛韦、更昔洛韦配伍的稳定性
2.
Preparation and Observation of Dissolution Characteristics of Ganciclovir Dispersible Tablets in Vitro;
更昔洛韦分散片的研制及体外溶出特性
3) Valganciclovir
缬更昔洛韦
1.
Determination the plasma concentration of valganciclovir and study on its pharmacokinetics in healthy volunteers;
液相色谱-串联质谱法测定缬更昔洛韦血药浓度及其在健康人体的药代动力学研究
2.
A new oral antiviral drug——valganciclovir;
口服抗病毒新药——缬更昔洛韦
3.
Review on the Synthesis of the New Antivirus Agent Valganciclovir;
新型抗病毒药物缬更昔洛韦的合成综述
4) Ganciclovir sodium
更昔洛韦钠
5) ganciclovir liposome
更昔洛韦脂质体
1.
Entrapment efficiency of ganciclovir liposome was evaluated by exclusion chromatography with Sephadex G-50 and UV.
采用逆相蒸发法制备更昔洛韦脂质体,同时对所制脂质体进行了表征和稳定性分析。
6) ganciclovir for injection
注射用更昔洛韦
1.
Research of Bacterial Endotoxin Test in Ganciclovir for Injection;
注射用更昔洛韦细菌内毒素检查法的实验研究
2.
A HPLC method for the determination of ganciclovir for injection was established.
采用 HPL C法测定注射用更昔洛韦含量。
3.
Objective To investigate bacterial endotoxin test of Ganciclovir for injection.
目的:建立快速的注射用更昔洛韦细菌内毒素检测法,替代热原检查法。
补充资料：更昔洛韦
分子式：C9H13N5O4
分子量：255.23
CAS号：82410-32-0
性质：暂无
制备方法：暂无
用途：抗病毒药。
分子量：255.23
CAS号：82410-32-0
性质：暂无
制备方法：暂无
用途：抗病毒药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条